Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy

被引：26
作者：
Athyros, Vasilios G. [3 ]
Mitsiou, Eydoxia K. [3 ]
Tziomalos, Konstantinos [2 ]
Karagiannis, Asterios [3 ]
Mikhailidis, Dimitri P. [1 ,4 ]
机构：
[1] Dept Surg, London NW3 2QG, England
[2] Aristotle Univ Thessaloniki, AHEPA Hosp, Sch Med, Propedeut Dept Internal Med 1, GR-54006 Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Hippocrat Hosp, Sch Med, Propedeut Dept Internal Med 2, GR-54006 Thessaloniki, Greece
[4] UCL, Sch Med, Dept Clin Biochem, Vasc Prevent Clin, London NW3 2QG, England
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2010年 / 11卷 / 05期
关键词：
CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; RENAL-FUNCTION; GREEK ATORVASTATIN; SUBGROUP ANALYSIS; SAFETY CONSIDERATIONS; INSULIN-RESISTANCE; END-POINTS; MELLITUS; EVENTS;
D O I：
10.1517/14656560903575654
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Importance of the field: The prevalence of chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM) is increasing. In turn, both CKD and T2DM are associated with increased risk of vascular events and progression to end-stage kidney disease (ESKD). In patients with DM, statin treatment can significantly improve estimated glomerular filtration rate (eGFR) or delay eGFR decline as well as significantly reduce CVD morbidity and mortality. In contrast, statins do not seem to decrease events in patients with advanced decline in kidney function. Areas covered in this review: This review considers the effects of statins and other lipid lowering drugs on kidney function and vascular events in patients with CKD and T2DM. What the reader will gain: Greater awareness of the links between CKD, T2DM, kidney function and vascular risk as well as the role of lipid-lowering drugs (mainly statins) in this field. Take home message: Current evidence points towards the need to prescribe statins in patients with T2DM before a major decline in kidney function occurs.
引用
收藏
页码：723 / 730
页数：8
相关论文
共 59 条
[1]  
Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
[2]  
[Anonymous], 2002, JAMA, V288, P2998
[3]   Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study [J].
Athyros, V. G. ;
Hatzitolios, A. ;
Karagiannis, A. ;
Didangelos, T. P. ;
Iliadis, F. ;
Dolgyras, S. ;
Vosnakidis, T. ;
Vasiliadis, P. ;
Malias, I. ;
Tziomalos, K. ;
Samouilidou, M. ;
Mikhailidis, D. P. .
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (08) :1931-1940
[4]   Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients [J].
Athyros, Vasilios G. ;
Kakafika, Anna I. ;
Papageorgiou, Athanasios A. ;
Pagourelias, Efstathios D. ;
Savvatianos, Savvas D. ;
Elisaf, Moses ;
Karagiannis, Asterios ;
Tziomalos, Konstantinos ;
Mikhailidis, Dimitri P. .
OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2007, 1 :8-14
[5]   Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome - A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study [J].
Athyros, Vasilios G. ;
Mikhailidis, Dimitri P. ;
Liberopoulos, Evangelos N. ;
Kakafika, Anna I. ;
Karagiannis, Asterios ;
Papageorgiou, Athanasios A. ;
Tziomalos, Konstantinos ;
Ganotakis, Emmanuel S. ;
Elisaf, Moses .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (01) :118-127
[6]   Statins and Cardiovascular Events in Patients with End-Stage Renal Disease on Hemodialysis. The AURORA Results Suggest the Need for Earlier Intervention [J].
Athyros, Vasilios G. ;
Tziomalos, Konstantinos ;
Karagiannis, Asterios ;
Mikhailidis, Dimitri P. .
CURRENT VASCULAR PHARMACOLOGY, 2009, 7 (03) :264-266
[7]   Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus - A subgroup analysis of the GREek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study [J].
Athyros, VG ;
Papageorgiou, AA ;
Symeonidis, AN ;
Didangelos, TP ;
Pehlivanidis, AN ;
Bouloukos, VI ;
Mikhailidis, DP .
ANGIOLOGY, 2003, 54 (06) :679-690
[8]   Statins and renal function in patients with diabetes mellitus [J].
Athyros, VG ;
Papageorgiou, AA ;
Elisaf, M ;
Mikhailidis, DP .
CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (07) :615-617
[9]   The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study [J].
Athyros, VG ;
Mikhailidis, DP ;
Papageorgiou, AA ;
Symeonidis, AN ;
Pehlivanidis, AN ;
Bouloukos, VI ;
Elisaf, M .
JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (07) :728-734
[10]  
ATHYROS VG, 2009, CURR VASC P IN PRESS
123456